{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7186,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de075-cd17-7685-9273-fb1c731af40f",
      "docSlug": "16b2d7592f4634ac7cd717a996934f07",
      "documentTitle": "Theravance Biopharma | Results Presentation Deck | 35 slides",
      "authorId": "theravance-biopharma",
      "authorName": "Theravance Biopharma",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "kpi_overview",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cd17-7685-9273-fb1c731af40f/23",
      "deckHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f",
      "deckAnchorHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 25,
          "from": 19,
          "beatId": "94e3fc43-5901-462d-839a-07bb0f06e654",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "The document outlines the company's financial update and expected milestones",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cd17-7685-9273-fb1c731af40f",
      "docSlug": "16b2d7592f4634ac7cd717a996934f07",
      "documentTitle": "Theravance Biopharma | Results Presentation Deck | 35 slides",
      "authorId": "theravance-biopharma",
      "authorName": "Theravance Biopharma",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "valuation_table",
      "function": "analyze_data",
      "notes": "The table displays projected royalties, net sales, and milestone payments from 2023 to 2026.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cd17-7685-9273-fb1c731af40f/24",
      "deckHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f",
      "deckAnchorHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 25,
          "from": 19,
          "beatId": "94e3fc43-5901-462d-839a-07bb0f06e654",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "The document outlines the company's financial update and expected milestones",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cd17-7685-9273-fb1c731af40f",
      "docSlug": "16b2d7592f4634ac7cd717a996934f07",
      "documentTitle": "Theravance Biopharma | Results Presentation Deck | 35 slides",
      "authorId": "theravance-biopharma",
      "authorName": "Theravance Biopharma",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "thesis_headline",
      "function": "present_solution",
      "notes": "Uses a curved arrow diagram to represent a progression or portfolio of value drivers.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cd17-7685-9273-fb1c731af40f/25",
      "deckHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f",
      "deckAnchorHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 25,
          "from": 19,
          "beatId": "94e3fc43-5901-462d-839a-07bb0f06e654",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "The document outlines the company's financial update and expected milestones",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cd17-7685-9273-fb1c731af40f",
      "docSlug": "16b2d7592f4634ac7cd717a996934f07",
      "documentTitle": "Theravance Biopharma | Results Presentation Deck | 35 slides",
      "authorId": "theravance-biopharma",
      "authorName": "Theravance Biopharma",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "closing_ask",
      "function": "state_next_steps",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cd17-7685-9273-fb1c731af40f/26",
      "deckHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f",
      "deckAnchorHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cd17-7685-9273-fb1c731af40f",
      "docSlug": "16b2d7592f4634ac7cd717a996934f07",
      "documentTitle": "Theravance Biopharma | Results Presentation Deck | 35 slides",
      "authorId": "theravance-biopharma",
      "authorName": "Theravance Biopharma",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "disclaimer",
      "function": "other",
      "notes": "Standard pharmaceutical product disclosure slide.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cd17-7685-9273-fb1c731af40f/27",
      "deckHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f",
      "deckAnchorHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cd17-7685-9273-fb1c731af40f",
      "docSlug": "16b2d7592f4634ac7cd717a996934f07",
      "documentTitle": "Theravance Biopharma | Results Presentation Deck | 35 slides",
      "authorId": "theravance-biopharma",
      "authorName": "Theravance Biopharma",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "key_messages",
      "function": "establish_context",
      "notes": "Includes a footnote referencing market research methodology.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cd17-7685-9273-fb1c731af40f/28",
      "deckHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f",
      "deckAnchorHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cd17-7685-9273-fb1c731af40f",
      "docSlug": "16b2d7592f4634ac7cd717a996934f07",
      "documentTitle": "Theravance Biopharma | Results Presentation Deck | 35 slides",
      "authorId": "theravance-biopharma",
      "authorName": "Theravance Biopharma",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 29,
      "slideType": "appendix",
      "function": "appendix",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cd17-7685-9273-fb1c731af40f/29",
      "deckHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f",
      "deckAnchorHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f#slide-29",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cd17-7685-9273-fb1c731af40f",
      "docSlug": "16b2d7592f4634ac7cd717a996934f07",
      "documentTitle": "Theravance Biopharma | Results Presentation Deck | 35 slides",
      "authorId": "theravance-biopharma",
      "authorName": "Theravance Biopharma",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes definitions for COPD, nOH, and PTE in the footer.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cd17-7685-9273-fb1c731af40f/30",
      "deckHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f",
      "deckAnchorHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f#slide-30",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cd17-7685-9273-fb1c731af40f",
      "docSlug": "16b2d7592f4634ac7cd717a996934f07",
      "documentTitle": "Theravance Biopharma | Results Presentation Deck | 35 slides",
      "authorId": "theravance-biopharma",
      "authorName": "Theravance Biopharma",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 31,
      "slideType": "revenue_buildup",
      "function": "present_framework",
      "notes": "The slide uses a mathematical equation format to explain the revenue recognition process.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cd17-7685-9273-fb1c731af40f/31",
      "deckHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f",
      "deckAnchorHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f#slide-31",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cd17-7685-9273-fb1c731af40f",
      "docSlug": "16b2d7592f4634ac7cd717a996934f07",
      "documentTitle": "Theravance Biopharma | Results Presentation Deck | 35 slides",
      "authorId": "theravance-biopharma",
      "authorName": "Theravance Biopharma",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 32,
      "slideType": "comparison_table",
      "function": "analyze_data",
      "notes": "The slide uses a split-panel layout to compare two distinct deal structures.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cd17-7685-9273-fb1c731af40f/32",
      "deckHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f",
      "deckAnchorHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f#slide-32",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cd17-7685-9273-fb1c731af40f",
      "docSlug": "16b2d7592f4634ac7cd717a996934f07",
      "documentTitle": "Theravance Biopharma | Results Presentation Deck | 35 slides",
      "authorId": "theravance-biopharma",
      "authorName": "Theravance Biopharma",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 33,
      "slideType": "other",
      "function": "other",
      "notes": "This slide serves as a reference or bibliography page for a conference presentation.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cd17-7685-9273-fb1c731af40f/33",
      "deckHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f",
      "deckAnchorHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f#slide-33",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cd17-7685-9273-fb1c731af40f",
      "docSlug": "16b2d7592f4634ac7cd717a996934f07",
      "documentTitle": "Theravance Biopharma | Results Presentation Deck | 35 slides",
      "authorId": "theravance-biopharma",
      "authorName": "Theravance Biopharma",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 34,
      "slideType": "before_after",
      "function": "present_solution",
      "notes": "Uses a before-after framing to justify a strategic pivot in clinical trial focus.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cd17-7685-9273-fb1c731af40f/34",
      "deckHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f",
      "deckAnchorHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f#slide-34",
      "loopMatches": [
        {
          "to": 35,
          "from": 34,
          "name": "Before After",
          "slug": "21-before-after",
          "bestFor": "Product demos, process improvements, ROI justification",
          "matchId": "2342bbb8-7106-4ccd-9663-bc88e95faeaa",
          "evidence": "The document shows a clear before-and-after comparison of the program's focus",
          "position": 0,
          "objective": "Highlighting the evolution of the program",
          "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta",
          "confidence": 0.6,
          "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cd17-7685-9273-fb1c731af40f",
      "docSlug": "16b2d7592f4634ac7cd717a996934f07",
      "documentTitle": "Theravance Biopharma | Results Presentation Deck | 35 slides",
      "authorId": "theravance-biopharma",
      "authorName": "Theravance Biopharma",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 35,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cd17-7685-9273-fb1c731af40f/35",
      "deckHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f",
      "deckAnchorHref": "/decks/019de075-cd17-7685-9273-fb1c731af40f#slide-35",
      "loopMatches": [
        {
          "to": 35,
          "from": 34,
          "name": "Before After",
          "slug": "21-before-after",
          "bestFor": "Product demos, process improvements, ROI justification",
          "matchId": "2342bbb8-7106-4ccd-9663-bc88e95faeaa",
          "evidence": "The document shows a clear before-and-after comparison of the program's focus",
          "position": 0,
          "objective": "Highlighting the evolution of the program",
          "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta",
          "confidence": 0.6,
          "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cdb7-7044-8ab7-a6598b346b12",
      "docSlug": "111bc891286750db42c6cb710d2a63cb",
      "documentTitle": "UBS | Fixed Income Presentation Deck | 44 slides",
      "authorId": "ubs",
      "authorName": "UBS",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7761332,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/6MEFyRgytzFEmne2Hu8Nbwlm2MVx_aiAIMHsqB8xco0/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xMTFiYzg5MTI4Njc1MGRiNDJjNmNiNzEwZDJhNjNjYi9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cdb7-7044-8ab7-a6598b346b12/1",
      "deckHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12",
      "deckAnchorHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 4,
          "from": 1,
          "beatId": "ab81eb4f-8a97-43d7-95cf-4a2f54a70c57",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Attention",
          "beatSlug": "monroes-sequence-attention",
          "evidence": "The document starts with key messages and an overview of UBS's strategy",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Hook",
          "parentBeatSlug": "hook"
        }
      ],
      "imagePathAlt": "https://imgproxy.kitesheet.com/WU56s9zUQvRxXvhz9AY9FqpMQTTUAwqSFXgLFZq9P-U/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xMTFiYzg5MTI4Njc1MGRiNDJjNmNiNzEwZDJhNjNjYi9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/wZsyAGioh14uTZvOR-z38yJ4ednE4YCqVqwqb1w5KxE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xMTFiYzg5MTI4Njc1MGRiNDJjNmNiNzEwZDJhNjNjYi9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/8VtLEiY_yR3SDzSlmPPmBUlwHIpXQgTl67Q2L6s0MS0/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xMTFiYzg5MTI4Njc1MGRiNDJjNmNiNzEwZDJhNjNjYi9wMDAxLnBuZw"
    },
    {
      "docId": "019de075-cdb7-7044-8ab7-a6598b346b12",
      "docSlug": "111bc891286750db42c6cb710d2a63cb",
      "documentTitle": "UBS | Fixed Income Presentation Deck | 44 slides",
      "authorId": "ubs",
      "authorName": "UBS",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7761332,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cdb7-7044-8ab7-a6598b346b12/2",
      "deckHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12",
      "deckAnchorHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 4,
          "from": 1,
          "beatId": "ab81eb4f-8a97-43d7-95cf-4a2f54a70c57",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Attention",
          "beatSlug": "monroes-sequence-attention",
          "evidence": "The document starts with key messages and an overview of UBS's strategy",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Hook",
          "parentBeatSlug": "hook"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cdb7-7044-8ab7-a6598b346b12",
      "docSlug": "111bc891286750db42c6cb710d2a63cb",
      "documentTitle": "UBS | Fixed Income Presentation Deck | 44 slides",
      "authorId": "ubs",
      "authorName": "UBS",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7761332,
      "pageNumber": 3,
      "slideType": "table_of_contents",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cdb7-7044-8ab7-a6598b346b12/3",
      "deckHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12",
      "deckAnchorHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 4,
          "from": 1,
          "beatId": "ab81eb4f-8a97-43d7-95cf-4a2f54a70c57",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Attention",
          "beatSlug": "monroes-sequence-attention",
          "evidence": "The document starts with key messages and an overview of UBS's strategy",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Hook",
          "parentBeatSlug": "hook"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cdb7-7044-8ab7-a6598b346b12",
      "docSlug": "111bc891286750db42c6cb710d2a63cb",
      "documentTitle": "UBS | Fixed Income Presentation Deck | 44 slides",
      "authorId": "ubs",
      "authorName": "UBS",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7761332,
      "pageNumber": 4,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cdb7-7044-8ab7-a6598b346b12/4",
      "deckHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12",
      "deckAnchorHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 4,
          "from": 1,
          "beatId": "ab81eb4f-8a97-43d7-95cf-4a2f54a70c57",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Attention",
          "beatSlug": "monroes-sequence-attention",
          "evidence": "The document starts with key messages and an overview of UBS's strategy",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Hook",
          "parentBeatSlug": "hook"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cdb7-7044-8ab7-a6598b346b12",
      "docSlug": "111bc891286750db42c6cb710d2a63cb",
      "documentTitle": "UBS | Fixed Income Presentation Deck | 44 slides",
      "authorId": "ubs",
      "authorName": "UBS",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7761332,
      "pageNumber": 5,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cdb7-7044-8ab7-a6598b346b12/5",
      "deckHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12",
      "deckAnchorHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12#slide-5",
      "loopMatches": [
        {
          "to": 10,
          "from": 5,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "323ff73d-01ae-446c-91cf-014007f48c03",
          "evidence": "UBS highlights the need for integration and cost reductions",
          "position": 0,
          "objective": "What are the consequences of not integrating Credit Suisse?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 5,
          "beatId": "f0c5d50e-7a92-4a55-a821-64d3a39d0e95",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Need",
          "beatSlug": "monroes-sequence-need",
          "evidence": "UBS highlights the need for integration and cost reductions",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cdb7-7044-8ab7-a6598b346b12",
      "docSlug": "111bc891286750db42c6cb710d2a63cb",
      "documentTitle": "UBS | Fixed Income Presentation Deck | 44 slides",
      "authorId": "ubs",
      "authorName": "UBS",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7761332,
      "pageNumber": 6,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": "The slide uses a four-column layout to delineate business units, each with a strategic objective and supporting bullet points.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cdb7-7044-8ab7-a6598b346b12/6",
      "deckHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12",
      "deckAnchorHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12#slide-6",
      "loopMatches": [
        {
          "to": 10,
          "from": 5,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "323ff73d-01ae-446c-91cf-014007f48c03",
          "evidence": "UBS highlights the need for integration and cost reductions",
          "position": 0,
          "objective": "What are the consequences of not integrating Credit Suisse?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 5,
          "beatId": "f0c5d50e-7a92-4a55-a821-64d3a39d0e95",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Need",
          "beatSlug": "monroes-sequence-need",
          "evidence": "UBS highlights the need for integration and cost reductions",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cdb7-7044-8ab7-a6598b346b12",
      "docSlug": "111bc891286750db42c6cb710d2a63cb",
      "documentTitle": "UBS | Fixed Income Presentation Deck | 44 slides",
      "authorId": "ubs",
      "authorName": "UBS",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7761332,
      "pageNumber": 7,
      "slideType": "propose_solution",
      "function": "propose_solution",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cdb7-7044-8ab7-a6598b346b12/7",
      "deckHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12",
      "deckAnchorHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12#slide-7",
      "loopMatches": [
        {
          "to": 10,
          "from": 5,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "323ff73d-01ae-446c-91cf-014007f48c03",
          "evidence": "UBS highlights the need for integration and cost reductions",
          "position": 0,
          "objective": "What are the consequences of not integrating Credit Suisse?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 5,
          "beatId": "f0c5d50e-7a92-4a55-a821-64d3a39d0e95",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Need",
          "beatSlug": "monroes-sequence-need",
          "evidence": "UBS highlights the need for integration and cost reductions",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cdb7-7044-8ab7-a6598b346b12",
      "docSlug": "111bc891286750db42c6cb710d2a63cb",
      "documentTitle": "UBS | Fixed Income Presentation Deck | 44 slides",
      "authorId": "ubs",
      "authorName": "UBS",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7761332,
      "pageNumber": 8,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The slide uses grouped bar charts to compare UBS and Credit Suisse performance metrics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cdb7-7044-8ab7-a6598b346b12/8",
      "deckHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12",
      "deckAnchorHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12#slide-8",
      "loopMatches": [
        {
          "to": 10,
          "from": 5,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "323ff73d-01ae-446c-91cf-014007f48c03",
          "evidence": "UBS highlights the need for integration and cost reductions",
          "position": 0,
          "objective": "What are the consequences of not integrating Credit Suisse?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 5,
          "beatId": "f0c5d50e-7a92-4a55-a821-64d3a39d0e95",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Need",
          "beatSlug": "monroes-sequence-need",
          "evidence": "UBS highlights the need for integration and cost reductions",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cdb7-7044-8ab7-a6598b346b12",
      "docSlug": "111bc891286750db42c6cb710d2a63cb",
      "documentTitle": "UBS | Fixed Income Presentation Deck | 44 slides",
      "authorId": "ubs",
      "authorName": "UBS",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7761332,
      "pageNumber": 9,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The slide details the composition of the Non-core and Legacy (NCL) perimeter, highlighting the wind-down of Credit Suisse assets.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cdb7-7044-8ab7-a6598b346b12/9",
      "deckHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12",
      "deckAnchorHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12#slide-9",
      "loopMatches": [
        {
          "to": 10,
          "from": 5,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "323ff73d-01ae-446c-91cf-014007f48c03",
          "evidence": "UBS highlights the need for integration and cost reductions",
          "position": 0,
          "objective": "What are the consequences of not integrating Credit Suisse?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 5,
          "beatId": "f0c5d50e-7a92-4a55-a821-64d3a39d0e95",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Need",
          "beatSlug": "monroes-sequence-need",
          "evidence": "UBS highlights the need for integration and cost reductions",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cdb7-7044-8ab7-a6598b346b12",
      "docSlug": "111bc891286750db42c6cb710d2a63cb",
      "documentTitle": "UBS | Fixed Income Presentation Deck | 44 slides",
      "authorId": "ubs",
      "authorName": "UBS",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7761332,
      "pageNumber": 10,
      "slideType": "propose_solution",
      "function": "propose_solution",
      "notes": "The chart shows a projected decline in RWA from 55bn in 2Q23 to 28bn in YE26.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cdb7-7044-8ab7-a6598b346b12/10",
      "deckHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12",
      "deckAnchorHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12#slide-10",
      "loopMatches": [
        {
          "to": 10,
          "from": 5,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "323ff73d-01ae-446c-91cf-014007f48c03",
          "evidence": "UBS highlights the need for integration and cost reductions",
          "position": 0,
          "objective": "What are the consequences of not integrating Credit Suisse?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 5,
          "beatId": "f0c5d50e-7a92-4a55-a821-64d3a39d0e95",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Need",
          "beatSlug": "monroes-sequence-need",
          "evidence": "UBS highlights the need for integration and cost reductions",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cdb7-7044-8ab7-a6598b346b12",
      "docSlug": "111bc891286750db42c6cb710d2a63cb",
      "documentTitle": "UBS | Fixed Income Presentation Deck | 44 slides",
      "authorId": "ubs",
      "authorName": "UBS",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7761332,
      "pageNumber": 11,
      "slideType": "propose_solution",
      "function": "present_solution",
      "notes": "The slide uses a logic flow from strategic levers (left) to financial targets (right).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cdb7-7044-8ab7-a6598b346b12/11",
      "deckHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12",
      "deckAnchorHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12#slide-11",
      "loopMatches": [
        {
          "to": 21,
          "from": 11,
          "name": "Hypothesis Test",
          "slug": "42-hypothesis-test",
          "bestFor": "Strategy validation, due diligence, research presentations",
          "matchId": "e850b26c-87ce-40d5-9049-8d7df41fb032",
          "evidence": "UBS presents its progress on cost reductions and financial performance",
          "position": 1,
          "objective": "Can UBS achieve its financial goals through integration?",
          "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)",
          "confidence": 0.7,
          "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 21,
          "from": 11,
          "beatId": "0953f5e5-8c1b-4cbb-970a-e4e1cd6c2d48",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "UBS presents its progress on cost reductions and financial performance",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cdb7-7044-8ab7-a6598b346b12",
      "docSlug": "111bc891286750db42c6cb710d2a63cb",
      "documentTitle": "UBS | Fixed Income Presentation Deck | 44 slides",
      "authorId": "ubs",
      "authorName": "UBS",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7761332,
      "pageNumber": 12,
      "slideType": "sop_buildup",
      "function": "present_solution",
      "notes": "The chart shows a bridge from current state to 2026 exit rate via four strategic levers.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cdb7-7044-8ab7-a6598b346b12/12",
      "deckHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12",
      "deckAnchorHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12#slide-12",
      "loopMatches": [
        {
          "to": 21,
          "from": 11,
          "name": "Hypothesis Test",
          "slug": "42-hypothesis-test",
          "bestFor": "Strategy validation, due diligence, research presentations",
          "matchId": "e850b26c-87ce-40d5-9049-8d7df41fb032",
          "evidence": "UBS presents its progress on cost reductions and financial performance",
          "position": 1,
          "objective": "Can UBS achieve its financial goals through integration?",
          "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)",
          "confidence": 0.7,
          "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 21,
          "from": 11,
          "beatId": "0953f5e5-8c1b-4cbb-970a-e4e1cd6c2d48",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "UBS presents its progress on cost reductions and financial performance",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cdb7-7044-8ab7-a6598b346b12",
      "docSlug": "111bc891286750db42c6cb710d2a63cb",
      "documentTitle": "UBS | Fixed Income Presentation Deck | 44 slides",
      "authorId": "ubs",
      "authorName": "UBS",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7761332,
      "pageNumber": 13,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cdb7-7044-8ab7-a6598b346b12/13",
      "deckHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12",
      "deckAnchorHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12#slide-13",
      "loopMatches": [
        {
          "to": 21,
          "from": 11,
          "name": "Hypothesis Test",
          "slug": "42-hypothesis-test",
          "bestFor": "Strategy validation, due diligence, research presentations",
          "matchId": "e850b26c-87ce-40d5-9049-8d7df41fb032",
          "evidence": "UBS presents its progress on cost reductions and financial performance",
          "position": 1,
          "objective": "Can UBS achieve its financial goals through integration?",
          "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)",
          "confidence": 0.7,
          "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 21,
          "from": 11,
          "beatId": "0953f5e5-8c1b-4cbb-970a-e4e1cd6c2d48",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "UBS presents its progress on cost reductions and financial performance",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cdb7-7044-8ab7-a6598b346b12",
      "docSlug": "111bc891286750db42c6cb710d2a63cb",
      "documentTitle": "UBS | Fixed Income Presentation Deck | 44 slides",
      "authorId": "ubs",
      "authorName": "UBS",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7761332,
      "pageNumber": 14,
      "slideType": "revenue_buildup",
      "function": "analyze_data",
      "notes": "The chart illustrates the impact of the Credit Suisse acquisition on 2Q23 results.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cdb7-7044-8ab7-a6598b346b12/14",
      "deckHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12",
      "deckAnchorHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12#slide-14",
      "loopMatches": [
        {
          "to": 21,
          "from": 11,
          "name": "Hypothesis Test",
          "slug": "42-hypothesis-test",
          "bestFor": "Strategy validation, due diligence, research presentations",
          "matchId": "e850b26c-87ce-40d5-9049-8d7df41fb032",
          "evidence": "UBS presents its progress on cost reductions and financial performance",
          "position": 1,
          "objective": "Can UBS achieve its financial goals through integration?",
          "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)",
          "confidence": 0.7,
          "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 21,
          "from": 11,
          "beatId": "0953f5e5-8c1b-4cbb-970a-e4e1cd6c2d48",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "UBS presents its progress on cost reductions and financial performance",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cdb7-7044-8ab7-a6598b346b12",
      "docSlug": "111bc891286750db42c6cb710d2a63cb",
      "documentTitle": "UBS | Fixed Income Presentation Deck | 44 slides",
      "authorId": "ubs",
      "authorName": "UBS",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7761332,
      "pageNumber": 15,
      "slideType": "valuation_table",
      "function": "show_valuation_bridge",
      "notes": "The slide uses two waterfall charts to explain the financial impact of the Credit Suisse acquisition.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cdb7-7044-8ab7-a6598b346b12/15",
      "deckHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12",
      "deckAnchorHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12#slide-15",
      "loopMatches": [
        {
          "to": 21,
          "from": 11,
          "name": "Hypothesis Test",
          "slug": "42-hypothesis-test",
          "bestFor": "Strategy validation, due diligence, research presentations",
          "matchId": "e850b26c-87ce-40d5-9049-8d7df41fb032",
          "evidence": "UBS presents its progress on cost reductions and financial performance",
          "position": 1,
          "objective": "Can UBS achieve its financial goals through integration?",
          "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)",
          "confidence": 0.7,
          "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 21,
          "from": 11,
          "beatId": "0953f5e5-8c1b-4cbb-970a-e4e1cd6c2d48",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "UBS presents its progress on cost reductions and financial performance",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cdb7-7044-8ab7-a6598b346b12",
      "docSlug": "111bc891286750db42c6cb710d2a63cb",
      "documentTitle": "UBS | Fixed Income Presentation Deck | 44 slides",
      "authorId": "ubs",
      "authorName": "UBS",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7761332,
      "pageNumber": 16,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The slide uses stacked bar charts to illustrate capital structure in absolute terms (bn) and relative terms (%), comparing current status to regulatory requirements.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cdb7-7044-8ab7-a6598b346b12/16",
      "deckHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12",
      "deckAnchorHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12#slide-16",
      "loopMatches": [
        {
          "to": 21,
          "from": 11,
          "name": "Hypothesis Test",
          "slug": "42-hypothesis-test",
          "bestFor": "Strategy validation, due diligence, research presentations",
          "matchId": "e850b26c-87ce-40d5-9049-8d7df41fb032",
          "evidence": "UBS presents its progress on cost reductions and financial performance",
          "position": 1,
          "objective": "Can UBS achieve its financial goals through integration?",
          "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)",
          "confidence": 0.7,
          "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 21,
          "from": 11,
          "beatId": "0953f5e5-8c1b-4cbb-970a-e4e1cd6c2d48",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "UBS presents its progress on cost reductions and financial performance",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-cdb7-7044-8ab7-a6598b346b12",
      "docSlug": "111bc891286750db42c6cb710d2a63cb",
      "documentTitle": "UBS | Fixed Income Presentation Deck | 44 slides",
      "authorId": "ubs",
      "authorName": "UBS",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7761332,
      "pageNumber": 17,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The chart shows the reduction of drawn SNB facilities from 120bn to 0 between March and August 2023.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-cdb7-7044-8ab7-a6598b346b12/17",
      "deckHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12",
      "deckAnchorHref": "/decks/019de075-cdb7-7044-8ab7-a6598b346b12#slide-17",
      "loopMatches": [
        {
          "to": 21,
          "from": 11,
          "name": "Hypothesis Test",
          "slug": "42-hypothesis-test",
          "bestFor": "Strategy validation, due diligence, research presentations",
          "matchId": "e850b26c-87ce-40d5-9049-8d7df41fb032",
          "evidence": "UBS presents its progress on cost reductions and financial performance",
          "position": 1,
          "objective": "Can UBS achieve its financial goals through integration?",
          "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)",
          "confidence": 0.7,
          "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 21,
          "from": 11,
          "beatId": "0953f5e5-8c1b-4cbb-970a-e4e1cd6c2d48",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "UBS presents its progress on cost reductions and financial performance",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}